Email Icon Facebook icon Twitter Icon GooglePlus Icon Contact

User Top Menu

Clinical and Research Fellowship: BioMend (Bioelectronic Medicine for Neuropsychiatric Disorders) Center

Posted: 25 Apr 2017
The Zucker Hillside Hospital Hofstra Northwell School of Medicine
Queens, New York, US

Neuromodulatory approaches including TMS (transcranial magnetic stimulation), tDCS (transcranial direct current stimulation), DBS (deep brain stimulation), as well as ECT (electroconvulsive therapy) are gaining increased clinical and research attention in the treatment of severe mental illness. The Zucker Hillside Hospital (a division of the Feinstein Institute for Medical Research and the Hofstra Northwell School of Medicine) has recently established the BioMend (Bioelectronic Medicine for Neuropsychiatric Disorders) Center to conduct cutting-edge clinical and research work focused on these non-pharmacological treatment strategies.

We are pleased to announce that a combined BioMend Clinical and Research Fellowship is now available beginning July 1, 2017, for individuals interested in attaining expertise in this rapidly developing field. The Zucker-Hillside Hospital is currently the clinical center for more than 6,000 treatments a year with ECT, TMS, and tDCS, and is conducting a number of research studies focused on the inter-individual variation in response to ECT, TMS, and tDCS treatment.

Our multidisciplinary team, in collaboration with neuropsychologists, neurologists, and neurosurgeons, provides comprehensive research opportunities in understanding the underlying neurobiology behind these approaches. Research approaches include basic clinical and neurocognitive studies, EEG and neuroimaging measures, as well as more invasive techniques using iEEG (intracranial EEG) and ECoG (electrocorticography) in human subjects. Fellows will have the opportunity to gain clinical expertise with these modalities (George Petrides, MD; Raphael Braga, MD; Miklos Argyelan, MD), as well as to conduct innovative clinical, neurophysiological, and neuroimaging research (Anil K. Malhotra, MD; Miklos Argyelan, MD; Ashesh Mehta, MD). We offer education and hands-on involvement in all phases of research design, implementation, data analysis, grant writing, and publication. Additional training opportunities with collaborators from the National Institutes of Health and other neuromodulation centers are also available.


Fellows must have completed a psychiatry residency.


Please email CV and letter of inquiry to:

Anil K. Malhotra, MD
Director of Research Psychiatry Research
The Zucker-Hillside Hospital
The Zucker-Hillside Hospital is an equal opportunity employer.